Show simple item record

Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect) : a parallel, two-group, randomised trial

dc.contributor.authorMiller, David
dc.contributor.authorPavitt, Susan
dc.contributor.authorSharma, Vinay
dc.contributor.authorForbes, Gordon
dc.contributor.authorHooper, Richard
dc.contributor.authorBhattacharya, Siladitya
dc.contributor.authorKirkman-Brown, Jackson
dc.contributor.authorCoomarasamy, Arri
dc.contributor.authorLewis, Sheena
dc.contributor.authorCutting, Rachel
dc.contributor.authorBrison, Daniel
dc.contributor.authorPacey, Allan
dc.contributor.authorWest, Robert
dc.contributor.authorBrian, Kate
dc.contributor.authorGriffin, Darren
dc.contributor.authorKhalaf, Yakoub
dc.date.accessioned2019-05-31T14:00:06Z
dc.date.available2019-05-31T14:00:06Z
dc.date.issued2019-02-02
dc.identifier144506902
dc.identifierda4d6a22-2e19-4ddf-8827-571982763bf2
dc.identifier30712901
dc.identifier85060705632
dc.identifier.citationMiller , D , Pavitt , S , Sharma , V , Forbes , G , Hooper , R , Bhattacharya , S , Kirkman-Brown , J , Coomarasamy , A , Lewis , S , Cutting , R , Brison , D , Pacey , A , West , R , Brian , K , Griffin , D & Khalaf , Y 2019 , ' Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect) : a parallel, two-group, randomised trial ' , The Lancet , vol. 393 , no. 10170 , pp. 416-422 . https://doi.org/10.1016/S0140-6736(18)32989-1en
dc.identifier.issn0140-6736
dc.identifier.otherPubMedCentral: PMC6409400
dc.identifier.urihttp://hdl.handle.net/2164/12345
dc.descriptionFunding: National Institute for Health Research Efficacy and Mechanism Evaluation Programme. Acknowledgments: This study was funded by the EME Programme (MREC 13/YH/0162; UKCRN ID 14845), a partnership of the Medical Research Council (MRC) and NIHR, and supported by the UK NIHR, the NIHR infrastructure in Leeds, and the UK Clinical Research Network. The views expressed in this publication are those of the authors and not necessarily those of the MRC, National Health Service, NIHR, or the UK Department of Health. The chief and principal investigators are thankful for the support of both the extended HABSelect Study Team and the NIHR Clinical Research Network, without whom the trial would not have been possible.en
dc.format.extent7
dc.format.extent220924
dc.language.isoeng
dc.relation.ispartofThe Lanceten
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectEmbryo Implantationen
dc.subjectEmbryo Transferen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectHyaluronic Acid/therapeutic useen
dc.subjectInfertility/therapyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPregnancyen
dc.subjectPregnancy Outcomeen
dc.subjectPregnancy Rateen
dc.subjectSperm Injections, Intracytoplasmicen
dc.subjectTreatment Outcomeen
dc.subjectUnited Kingdomen
dc.subjectR Medicineen
dc.subjectMedical Research Council (MRC)en
dc.subjectMREC 13/YH/0162en
dc.subjectUKCRN ID 14845en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titlePhysiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect) : a parallel, two-group, randomised trialen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1016/S0140-6736(18)32989-1


Files in this item

Thumbnail
Name:
Physiological_hyaluronan_selec ...
Size:
215.7Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record